Cheng C L, Saw S M, Pang C E, Chee C
Singapore National Eye Centre, Singapore Eye Research Institute, 11 Third Hospital Avenue, Singapore.
Singapore Med J. 2009 Feb;50(2):126-31.
This study aimed to describe the morphology of age-related macular degeneration (AMD) as well as to obtain an estimate of the population-based incidence rate in Singapore.
This is a retrospective hospital-based study of AMD cases seen in 1991 and 1992 at the Singapore National Eye Centre (SNEC), a tertiary eye centre. All case notes recorded with the International Classification of Diseases, ninth revision, clinical modification code '362.5', which is 'degenerations of the macula', were retrieved and analysed. Only case notes of patients who were aged 50 years and above and with documented AMD were included in the study.
There were 41 (21.8 percent) patients with drusen alone, 39 (20.7 percent) with dry AMD and 108 (57.5 percent) with exudative AMD. The morphology of the disease was similar among the Chinese and non-Chinese and there were no gender differences. A significant majority of patients with dry and exudative AMD had legal blindness at presentation (p-value is less than 0.0001). Notably, 27 (33.3 percent) patients with exudative AMD had improved vision with time. In comparison, the majority of patients with dry AMD or drusen alone tended to have the same or worsening visual acuity over time. The two-year SNEC hospital incidence rate of AMD in 1991-1992 was 0.38 percent or equivalent to 3.8 per 1,000 new cases seen at SNEC. The estimated population-based incidence rate of exudative AMD was 0.02 percent.
The population incidence of exudative AMD is lower but comparable to the Western population. Patients with exudative AMD tend to have poorer vision as compared to patients with geographical atrophy or drusen. The proportion of exudative AMD to geographical atrophy appears to be higher than in the West.
本研究旨在描述年龄相关性黄斑变性(AMD)的形态,并估算新加坡基于人群的发病率。
这是一项基于医院的回顾性研究,研究对象为1991年和1992年在新加坡国立眼科中心(SNEC,一家三级眼科中心)就诊的AMD患者。检索并分析了所有记录有国际疾病分类第九版临床修订版代码“362.5”(即“黄斑变性”)的病历。本研究仅纳入年龄在50岁及以上且有记录的AMD患者的病历。
仅有玻璃膜疣的患者有41例(21.8%),干性AMD患者有39例(20.7%),渗出性AMD患者有108例(57.5%)。疾病形态在华人和非华人中相似,且无性别差异。干性和渗出性AMD患者中,绝大多数在就诊时已达法定盲标准(p值小于0.0001)。值得注意的是,27例(33.3%)渗出性AMD患者视力随时间有所改善。相比之下,大多数仅有干性AMD或玻璃膜疣的患者视力随时间趋于相同或恶化。1991 - 1992年SNEC医院AMD的两年发病率为0.38%,相当于每1000例在SNEC就诊的新病例中有3.8例。渗出性AMD的基于人群的估计发病率为0.02%。
渗出性AMD的人群发病率较低,但与西方人群相当。与地图状萎缩或玻璃膜疣患者相比,渗出性AMD患者的视力往往较差。渗出性AMD与地图状萎缩的比例似乎高于西方。